PHARMASGP: Hauptsache gesund – FOCUS online

Das Unternehmen: PharmaSGP is a Consumer-Health-Unternehmen. The Unternehmen have a free medicine and distribute this main meal in Pharmacies. Solche Arzneimittel became available as an OTC (“Over-The-Counter”) product. Damit agers PharmaSGP on the “Gesundheit” of Zukunftsfeld. The action can no longer take place. Zudem is the market capitalization of the German Nebenwertes with a value of 280 million euros. Invest now in small bets and order the promotional limit.

Die Zahlen: Der Umsatz is ready to double the Geschäftsjahr 2017. If you win the deal, it will continue throughout 2020 and you will receive a compensation of 1.38 Euro. The mirror is bigger in the Ausschüttungspolitik of PharmaSGP – the dividend yield is on the market. The outdoor life is recreated on the Tellerrand and the factory, the European prices.

The view: Der Ausblick: PharmaSGP is a more interesting topic. The few analysts, who are civilized by the action, are immobile. Set the stop at 20.20 Euro.

DR